1. Respiratory and Immunology, BioPharmaceuticals Medical,
2. Pulmonary and Critical Care Medicine, Allergy & Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
3. Biometrics, Late-stage Development,
4. Global Medical Affairs,
5. Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom;
6. University of Leicester, Leicester, United Kingdom;
7. Biometrics, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden;
8. IKF Pneumologie Mainz, Mainz, Germany;
9. Thoraxklinik Heidelberg, Heidelberg, Germany; and
10. Royal Brompton and Harefield Hospitals, London, United Kingdom
11. Global Development, and
12. Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland;
13. Translational Medicine, Amgen, Thousand Oaks, California;